Dalton, Greiner, Hartman, Maher & Co’s St Jude Medical STJ Stock Holding History

Dalton, Greiner, Hartman, Maher & Co’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-114,058	Closed	-$8.9M	–	186
2016 Q2	$8.9M	Buy	114,058 +106,557	+1,421%	+$7.6M	0.55%	94
2016 Q1	$413K	Buy	7,501 +1,754	+31%	+$95.6K	0.03%	166
2015 Q4	$355K	Sell	5,747 -85,185	-94%	-$5.37M	0.02%	174
2015 Q3	$5.74M	Buy	90,932 +521	+0.6%	+$37.2K	0.32%	96
2015 Q2	$6.61M	Buy	90,411 +84,278	+1,374%	+$6.09M	0.34%	99
2015 Q1	$401K	Buy	6,133 +1,626	+36%	+$108K	0.02%	180
2014 Q4	$293K	Buy	+4,507	New	+$290K	0.02%	177

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dalton, Greiner, Hartman, Maher & Co's STJ Position: Q3 2016 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 114,058 shares — an estimated $8.9M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in STJ in Q4 2014 and held it in 7 quarters. The position peaked at $8.9M in Q2 2016. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

Dalton, Greiner, Hartman, Maher & Co reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
Dalton, Greiner, Hartman, Maher & Co sold 114,058 St Jude Medical shares in Q3 2016, an estimated $8.9M.
Dalton, Greiner, Hartman, Maher & Co first reported a position in St Jude Medical in Q4 2014 and held it in 7 quarters.
Dalton, Greiner, Hartman, Maher & Co's St Jude Medical position peaked at $8.9M in Q2 2016.
570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q3 2016, filed 13 Oct 2016.